Viewing Study NCT00130169


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2025-12-31 @ 2:23 AM
Study NCT ID: NCT00130169
Status: COMPLETED
Last Update Posted: 2015-07-01
First Post: 2005-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies
Sponsor: Eisai Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module